Frank J. DellaFera
Prior to building Fera Pharmaceuticals, Frank held the esteemed position of CEO and President of Sandoz US, one of the world’s largest and most successful generic pharmaceutical companies. Before his appointment to CEO at Sandoz US, he served as Vice President, Sales and Marketing for the organization. From 1996 to 2005, Frank was Vice President, Sales and Marketing at Eon Labs, which was acquired by Sandoz. Earlier in his career, Frank held several sales and marketing positions, including Senior Regional Sales Director for Dura Pharmaceuticals. Additionally, Frank served in management and business development capacities for Ben Venue Laboratories, Inc. and American Regent Laboratories Inc. He began his career at Eli Lilly and Company as a field sales representative, where he was promoted to Hospital Sales Specialist. Frank received a B.S. degree in Pharmacy from the College of Pharmacy, St. John’s University.